335066248	335066248	CD	B-NP	O
|	|	NN	I-NP	O
MOV	MOV	NN	I-NP	O
|	|	NN	I-NP	O
03031085	03031085	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8802992	8802992	CD	B-NP	O
|	|	CC	I-NP	O
4/2/2005	4/2/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
UTI	UTI	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/10/2005	4/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/6/2005	9/6/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
ROSSMANN	ROSSMANN	NNP	B-NP	O
,	,	,	O	O
ANTONY	ANTONY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
846-29-54-0	846-29-54-0	CD	I-NP	O
Ingoak	Ingoak	NNP	I-NP	O
Aemi	Aemi	NNP	I-NP	O
Jose	Jose	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/25/05	2/25/05	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
RISDEN	RISDEN	NNP	B-NP	O
,	,	,	O	O
GREGORIO	GREGORIO	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ELAVIL	ELAVIL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/30/05	10/30/05	CD	B-NP	O
by	by	IN	B-PP	O
ALATTAR	ALATTAR	NNP	B-NP	O
,	,	,	O	O
MAXWELL	MAXWELL	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
45923477	45923477	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	B-protein
ATENOLOL	ATENOLOL	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
CIPROFLOXACIN	CIPROFLOXACIN	NN	I-NP	I-protein
250	250	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q12H	Q12H	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

FLUOXETINE	FLUOXETINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/30/05	10/30/05	CD	B-NP	O
by	by	IN	B-PP	O
IMADA	IMADA	NNP	B-NP	O
,	,	,	O	O
TERRY	TERRY	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/30/05	10/30/05	CD	B-NP	O
by	by	IN	B-PP	O
TANCER	TANCER	NN	B-NP	B-DNA
,	,	,	O	O
LEONARD	LEONARD	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
12862833	12862833	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
AMLODIPINE	AMLODIPINE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

VICODIN	VICODIN	NN	B-NP	O
-LRB-	-LRB-	SYM	O	O
HYDROCODONE	HYDROCODONE	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
+	+	SYM	B-NP	O
APAP	APAP	NN	I-NP	B-protein
-RRB-	-RRB-	SYM	I-NP	O
1-2	1-2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/2	9/2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
ECASA	ECASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
previously	previously	RB	I-NP	O
scheduled	schedule	VBN	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

6/6/05	6/6/05	CD	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
ORPHENADRINE	ORPHENADRINE	NNP	B-NP	O
CITRATE	CITRATE	NNP	I-NP	O
,	,	,	O	O
ANGIOTENSIN	ANGIOTENSIN	NNP	B-NP	B-protein
CONVERTING	CONVERTING	NNP	I-NP	I-protein
ENZYME	ENZYME	NNP	I-NP	I-protein
INHIBITOR	INHIBITOR	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
UTI	UTI	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
UTI	UTI	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
?	?	.	O	O

CARDIOMYOPATHY	CARDIOMYOPATHY	NN	B-NP	O
EF	EF	NN	I-NP	O
=	=	SYM	B-VP	O
39	39	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
1989	1989	CD	B-NP	O
HTN	HTN	NN	I-NP	O
SEVERE	SEVERE	NN	I-NP	O
HYPERCHOL/HYPER	HYPERCHOL/HYPER	NN	I-NP	O
TG	TG	NN	I-NP	O
POORLY	POORLY	NN	I-NP	O
CONTROLLED	CONTROLLED	VBD	B-VP	O
DM	DM	NNP	B-NP	O
S/P	S/P	NNP	I-NP	O
CHOLE/APPY/TAH	CHOLE/APPY/TAH	NNP	I-NP	O
DIFFUSE	DIFFUSE	NNP	I-NP	O
ABDOMINAL	ABDOMINAL	NNP	I-NP	O
PAIN	PAIN	NNP	I-NP	O
ELEVATED	ELEVATED	NNP	I-NP	O
LIPASE	LIPASE	NNP	I-NP	O
ALLG	ALLG	NNP	I-NP	O
:	:	:	O	O
SULFA/AMOXICILLIN	SULFA/AMOXICILLIN	NNP	B-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Labs	Labs	NNP	I-NP	O
,	,	,	O	O
Antibiotis	Antibiotis	NNP	B-NP	O
,	,	,	O	O
CXR	CXR	NNP	B-NP	B-protein
,	,	,	O	O
EKG	EKG	NNP	B-NP	O
,	,	,	O	O
Telemetry	Telemetry	NNP	B-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
n/v/diarrhea	n/v/diarrhea	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
66	66	CD	B-NP	O
y	y	NN	I-NP	O
'	'	POS	B-NP	O
o	o	NN	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
Hypercholesterolemia	Hypercholesterolemia	NNP	B-NP	O
,	,	,	O	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	B-protein
USOH	USOH	NN	I-NP	I-protein
until	until	IN	B-PP	I-protein
3	3	CD	B-NP	I-protein
wks	wk	NNS	I-NP	I-protein
ago	ago	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
vague	vague	JJ	B-NP	O
abd	abd	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abd	abd	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
progressed	progress	VBD	B-VP	O
and	and	CC	O	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
onset	onset	NN	I-NP	O
n/v/diarrhea	n/v/diarrhea	NN	I-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
and	and	CC	O	O
subjective	subjective	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
some	some	DT	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
melena	melena	NN	I-NP	O
,	,	,	O	O
BRBPR	BRBPR	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
gross	gross	JJ	I-NP	O
hematuria	hematuria	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
=	=	SYM	B-VP	O
99.0	99.0	CD	B-NP	O
HR	HR	NN	I-NP	O
=	=	SYM	B-VP	O
72	72	CD	B-NP	O
BP	BP	NN	I-NP	O
=	=	SYM	B-VP	O
130-170/82	130-170/82	CD	B-NP	O
-96	-96	CD	I-NP	O
in	in	IN	B-PP	O
R	R	NN	B-NP	O
arm	arm	NN	I-NP	O
,	,	,	O	O
102-130/82	102-130/82	CD	B-NP	O
-100	-100	CD	I-NP	O
in	in	IN	B-PP	O
L	L	NN	B-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
=	=	SYM	B-VP	O
20	20	CD	B-NP	O
02sat	02sat	NN	I-NP	O
=	=	SYM	B-VP	O
95	95	CD	B-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

NAD	NAD	NN	B-NP	O
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
slightly	slightly	RB	B-NP	O
dry	dry	JJ	I-NP	O
MM	MM	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
7cm	7cm	NN	I-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
Nl	Nl	NN	I-NP	I-protein
s1	s1	NN	I-NP	I-protein
and	and	CC	I-NP	O
s2	s2	NN	I-NP	B-protein
.	.	.	O	O

2/6	2/6	CD	B-NP	O
SEM	SEM	NN	I-NP	O
audible	audible	JJ	I-NP	O
throughout	throughout	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
r/g	r/g	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
CTAB	CTAB	NN	I-NP	B-protein
.	.	.	O	O

Abd	Abd	NNP	B-NP	O
Soft	Soft	NNP	I-NP	O
,	,	,	O	O
ND	ND	NNP	B-NP	O
.	.	.	O	O

Bsx4	Bsx4	NN	B-NP	B-protein
.	.	.	O	O

Diffusely	Diffusely	RB	B-NP	O
tender	tender	NN	I-NP	O
.	.	.	O	O

NO	NO	NN	B-NP	O
CVAT	CVAT	NN	I-NP	O
.	.	.	O	O

Poor	Poor	NN	B-NP	O
DPP	DPP	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

A/P	A/P	NN	B-NP	O
:	:	:	O	O
66	66	CD	B-NP	O
y	y	NN	I-NP	O
'	'	POS	B-NP	O
o	o	NN	I-NP	O
owman	owman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	B-protein
p/w	p/w	NN	I-NP	I-protein
n/v/f	n/v/f	NN	I-NP	I-protein
/	/	SYM	B-NP	O
c	c	NN	I-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
and	and	CC	I-NP	O
ARF	ARF	NN	I-NP	B-protein
.	.	.	O	O

Also	Also	RB	B-ADJP	O
notable	notable	JJ	I-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V3-V5	V3-V5	NN	B-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ID-UTI	ID-UTI	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
Rx	Rx	NN	I-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
cxs	cx	NNS	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
100.00	100.00	CD	I-NP	O
E.Coli	E.Coli	NNP	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cx	cx	NN	I-NP	O
without	without	IN	B-PP	O
growth	growth	NN	B-NP	O
.	.	.	O	O

Improvement	Improvement	NN	B-NP	O
in	in	IN	B-PP	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
CVAT	CVAT	NN	I-NP	B-protein
after	after	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
IV	IV	CD	B-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Renal	Renal	JJ	I-NP	O
-	-	HYPH	I-NP	O
ARF	ARF	NN	I-NP	B-protein
likely	likely	RB	B-ADJP	O
prerenal	prerenal	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
UTI/infection	UTI/infection	NN	B-NP	O
and	and	CC	O	O
pre-renal	pre-renal	JJ	B-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

NS	NS	NN	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
with	with	IN	B-PP	O
complete	complete	JJ	B-NP	O
return	return	NN	I-NP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
CV	CV	NN	I-NP	O
-	-	HYPH	I-NP	O
Pump	Pump	NN	I-NP	O
:	:	:	O	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

Holding	Hold	VBG	B-VP	O
lasix	lasix	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
UTI.Hx	UTI.Hx	NN	B-NP	B-protein
of	of	IN	B-PP	O
asymmetric	asymmetric	JJ	B-NP	O
BPs	BP	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
stenosis	stenosis	NN	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
First	First	JJ	B-NP	O
degree	degree	NN	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
intermittent	intermittent	JJ	B-NP	O
Wenkebach	Wenkebach	NN	I-NP	O
but	but	CC	O	O
infrequently	infrequently	RB	B-VP	O
dropped	drop	VBD	I-VP	O
beats	beat	NNS	B-NP	O
so	so	IN	B-SBAR	O
no	no	DT	B-NP	O
contraindication	contraindication	NN	I-NP	O
to	to	TO	B-PP	O
nodal	nodal	JJ	B-NP	O
blockade	blockade	NN	I-NP	O
.	.	.	O	O

Telemetry	Telemetry	NNP	B-NP	O
.	.	.	O	O

Ischemia	Ischemia	NNP	B-NP	O
:	:	:	O	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V3-V	V3-V	NN	B-NP	O
%	%	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
during	during	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

MI	MI	NN	B-NP	O
r/o	r/o	NN	I-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

One	One	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
jaw	jaw	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
relieved	relieve	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
SL	SL	NN	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
outpatient	outpatient	NN	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
-	-	HYPH	B-NP	O
ETT	ETT	NN	I-NP	B-DNA
MIBI	MIBI	NN	I-NP	I-DNA
or	or	CC	I-NP	O
adenosine	adenosine	NN	I-NP	O
MIBI	MIBI	NNP	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	O	O
Endo	Endo	AFX	O	B-protein
-	-	HYPH	O	O
ISS	ISS	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
FEN	FEN	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
DVT	DVT	NN	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
diet	diet	NN	I-NP	I-protein
FULL	FULL	NN	I-NP	I-protein
CODE	CODE	NN	I-NP	I-protein
FULL	FULL	NN	I-NP	I-protein
CODE	CODE	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Renal	Renal	JJ	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
please	please	VB	B-VP	O
take	take	VBP	B-VP	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
250mg	250mg	NN	I-NP	O
every	every	DT	B-NP	O
12hrs	12hr	NNS	I-NP	O
for	for	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
please	please	VB	B-VP	O
take	take	VBP	B-VP	O
ECASA	ECASA	NN	B-NP	O
81mg	81mg	NN	I-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
scheduled	scheduled	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
insure	insure	NN	I-NP	O
UTI	UTI	NNP	I-NP	O
cleared	clear	VBD	B-VP	O
with	with	IN	B-PP	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
.	.	.	O	O

Please	Please	NNP	B-NP	O
Schedule	Schedule	NNP	I-NP	O
patient	patient	NN	I-NP	O
for	for	IN	B-PP	O
adenosine	adenosine	NN	B-NP	O
or	or	CC	I-NP	O
ETT	ETT	NN	I-NP	B-DNA
MIBI	MIBI	NN	I-NP	I-DNA
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
angina	angina	NN	B-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BIGAS	BIGAS	NNP	B-NP	O
,	,	,	O	O
SYDNEY	SYDNEY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TJ09	TJ09	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/25/05	2/25/05	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
21	21	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

